Aptamer Group wins new contracts with global pharmaceutical leaders
Aptamer Group plc (AIM: APTA), an innovator in the life sciences sector, has announced new agreements worth up to £275,000 for the development of its proprietary Optimer binders. These agreements involve three of the top ten global pharmaceutical companies and underline the expanding commercial interest in Aptamer’s technology. The deals also include potential for additional […]